Description: PT Pyridam Farma Tbk develops, produces, and sells pharmaceuticals, antibiotics, vitamins, supplements, and traditional herbal care products in Indonesia. The company operates in two segments, Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. It offers medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR " extraction kit and extractor machine, speciment bag, sterile container, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; products in the areas of alimentary t. and metabolism, blood and blood forming organs, cardiovascular system, dermatologicals, G.U. system and sex hormones, systemic corticosteroids, systemic antibacterial, sensory organs, as well as musculo-skeletal, nervous, and respiratory systems; and supplements and other preventive consumer health products with energy drinks and healthy ready-to-drink products. In addition, it engages in the research and development on biotechnology, life, and medical science. The company was founded in 1976 and is headquartered in Jakarta, Indonesia.
Home Page: www.pyfa.co.id
Sinarmas MSIG Tower
Jakarta,
12920
Indonesia
Phone:
62 21 5099 1067
Officers
| Name | Title |
|---|---|
| Mr. Yan Gwan Lee | Pres Director |
| Mr. Yenfrino Gunadi | CFO & Director |
| Dr. Paulus Widjanarko Brotosaputro | COO, Head of Pharmacovigilance & Director |
| Sinta Lestari Ningsih | Fin., Accounting, & Tax Mang. |
| Ms. Nadia Miranty Verdiana | Head of Legal & Corp. Sec. |
| Joshua Sandjaja | HRD Mang. |
| Andrey Septiana | Head of OTC |
| Ms. - Yoshiana | Head of Internal Audit Unit |
Exchange: JK
Country: ID
Currency: Indonesian Rupiah (Rp)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 1.6245 |
| Price-to-Book MRQ: | 1.121 |
| Price-to-Sales TTM: | 0.6489 |
| IPO Date: | 2001-10-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 1163 |